Home » Topics » BioWorld Science

BioWorld Science
RSS

Masitinib reduces severe asthma exacerbation rate in phase III study

Nov. 8, 2019

Researchers divulge new compounds for malaria

Nov. 8, 2019

Supernus Pharmaceuticals provides data from phase III P301 study of SPN-810

Nov. 8, 2019

AAV encoding NUsc1 rescues memory in Alzheimer's disease model

Nov. 8, 2019

Novel gene therapy for the treatment of Alzheimer's disease

Nov. 8, 2019

Merck KGaA starts phase III study of L-praziquantel orodispersible in Schistosoma-infected children

Nov. 8, 2019

Recombinant human thrombomodulin evaluated for ARDS with disseminated intravascular coagulation

Nov. 8, 2019

Psioxus Therapeutics presents series of oncolytic viral compounds for cancer

Nov. 8, 2019

Novel nonhuman primate model of induced colitis

Nov. 8, 2019

Antisense therapy with antagomiR-23b shows promise for the treatment of DM1

Nov. 8, 2019

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...